Biomarker test company Cleveland HeartLab made a splash recently at TEDMED, with about 500 conference-goers taking the company’s heart inflammation tests.
Results of the TEDMED tests showed that 41 percent of those who submitted samples had high cholesterol or low HDL (good cholesterol), 28 percent showed evidence of hardening of the arteries and 12 percent tested positive for plaque in the arteries.
Cleveland HeartLab founder and chief science officer Dr. Marc Penn presented the results on stage at TEDMED.
“We’re looking at classic risk factors like lipids,” Penn said. “We’re also looking at inflammatory markers that not only define whether you have hardening of the artery, but also define whether your artery is active and at-risk for a cardiovascular event, such as stroke or heart attack.”
Watch the video below to see Penn’s presentation.
